Causal Association of Obesity and Dyslipidemia with Type 2 Diabetes: A Two-Sample Mendelian Randomization Study
Overview
Authors
Affiliations
Recent studies have suggested an association between obesity and dyslipidemia in the development of type 2 diabetes (T2D). The purpose of this study was to explore the causal effects of obesity and dyslipidemia on T2D risk in Asians. Two-sample Mendelian randomization (MR) analyses were performed to assess genetically predicted obesity using body mass index (BMI) and dyslipidemia using high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), total cholesterol (TCHL), and triglycerides (TG) versus T2D susceptibility using genome-wide association study (GWAS) results derived from the summary statistics of Biobank Japan ( = 179,000) and DIAbetes Meta-ANalysis of Trans-Ethnic association studies ( = 50,533). The MR analysis demonstrated evidence of a causal effect of higher BMI on the risk of T2D (odds ratio (OR) > 1.0, < 0.05). In addition, TG showed a protective effect on the risk of T2D (ORs 0.68-0.85). However, HDL, LDL, and TCHL showed little genetic evidence supporting a causal association between dyslipidemia and T2D. We found strong genetic evidence supporting a causal association of BMI with T2D. Although HDL, LDL, and TCHL did not show a causal association with T2D, TG had a causal relationship with the decrease of T2D. Although it was predicted that TG would be linked to a higher risk of T2D, it actually exhibited a paradoxical protective effect against T2D, which requires further investigation.
Lee Y, Seo J J Clin Med. 2025; 13(24.
PMID: 39768593 PMC: 11678446. DOI: 10.3390/jcm13247670.
Identification of genetic loci enriched in obese or lean T2D cases in the Korean population.
Lim E, Cho Y Genes Genomics. 2024; 47(2):235-243.
PMID: 39693004 DOI: 10.1007/s13258-024-01602-x.
Seo J, Lee Y, Choi H Biomedicines. 2024; 12(10).
PMID: 39457566 PMC: 11504051. DOI: 10.3390/biomedicines12102253.
Lipidomics profiling and circulating triglyceride concentrations in sub-Saharan African individuals.
Bentley A, Doumatey A, Zhou J, Lei L, Meeks K, Heuston E Sci Rep. 2024; 14(1):20834.
PMID: 39251667 PMC: 11385232. DOI: 10.1038/s41598-024-71734-3.
Liu H, Yao X, Wang L, Liu J, Li X, Fu X Front Endocrinol (Lausanne). 2024; 15:1358358.
PMID: 38863932 PMC: 11165179. DOI: 10.3389/fendo.2024.1358358.